Abstract
Midazolam is now the first-line treatment for status epilepticus in children. The drug can be given via several different routes. Transmucosal administration is safe, effective, easier to use and more socially acceptable than rectal diazepam. The aim is to stop convulsive seizures that have lasted longer than five minutes as soon as possible. Transmucosal pre-hospital administration by carers is recommended for patients with a predilection for prolonged seizures, or those with limited access to emergency services. This reduces the time to treat and improves outcomes. General practitioners can obtain midazolam through the Prescriber Bag Drug Supplies section of the Pharmaceutical Benefits Scheme. For pre-hospital use, 5 mg in 1 mL plastic ampoules is recommended.
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
